A detailed history of Founders Financial Securities LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Founders Financial Securities LLC holds 1,777 shares of NVO stock, worth $154,901. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,777
Previous 3,709 52.09%
Holding current value
$154,901
Previous $529,000 60.11%
% of portfolio
0.02%
Previous 0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$119.07 - $145.42 $230,043 - $280,951
-1,932 Reduced 52.09%
1,777 $211,000
Q2 2024

Aug 02, 2024

BUY
$122.71 - $146.91 $247,506 - $296,317
2,017 Added 119.21%
3,709 $529,000
Q1 2024

Apr 17, 2024

BUY
$102.11 - $135.92 $172,770 - $229,976
1,692 New
1,692 $217,000
Q4 2017

Jan 25, 2018

SELL
$47.53 - $53.73 $524,398 - $592,803
-11,033 Closed
0 $0
Q3 2017

Nov 09, 2017

BUY
$41.15 - $49.22 $454,007 - $543,044
11,033
11,033 $531,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Founders Financial Securities LLC Portfolio

Follow Founders Financial Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Founders Financial Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Founders Financial Securities LLC with notifications on news.